INTRODUCTION
Assays for detection of reverse transcriptase (RT) activity are important tools in detection and quantitation of retroviruses. Recently developed assays for RT are based on polymerase chain reaction (PCR) assays in which an exogenous RNA template is transcribed by RT activity in the test sample, and the resulting cDNA copies are amplified by PCR. PCR products are then quantitated by Southern blot or enzyme-linked immunosorbent assay (ELISA) (6, 19, 21, 23) . These PCR-based RT assays are approximately a millionfold more sensitive than conventional homopolymeric RT assays, and because they detect RT rather than conserved amplifiable DNA sequences, they can be used for detection of a wide range of human and animal retroviruses.
We have repeated one of these highly sensitive PCR-based RT assays, the product-enhanced reverse transcriptase (PERT) assay described by Pyra et al. (19) , by using an avian myeloblastosis virus (AMV) RT standard with results similar to the original publication. Using recently developed technology, we have modified the PERT assay into a one-step fluorescent probe-based PCR assay. This new technology utilizes the 5 ′ nuclease activity of TaqDNA polymerase to digest a hybridization probe labeled with both a fluorescent reporter dye and quencher dye, which results in a quantifiable signal during PCR amplification (1, 7, 11, 12) . The fluorescent reporter dye FAM is covalently linked to the 5 ′ end of the probe, and the fluorescent quencher dye TAMRA is located near the 3 ′ end. In addition, the probe contains a 3 ′ -blocking phosphate group to prevent probe extension during amplification (17) . When the probe is intact, the reporter dye's fluorescent emission is suppressed due to the close proximity of the quencher dye. During PCR, if the target sequence is present, the probe specifically anneals between the forward and reverse primers. The 5 ′→3 ′ nuclease activity of the Taq DNA polymerase cleaves the annealed probe between the reporter and quencher dyes, thereby releasing a measurable increase in fluorescence. The cleaved probe is then displaced, and polymerization of the strand continues (4, 5, 18) . A detector monitors the increase in fluorescent emission in real time without further post-PCR analysis. Therefore, the assay can be completed entirely in approximately 5 h without losing assay sensitivity. Since the TaqDNA polymerase does not digest free probe and fluorescent emission requires that both primer and probe are complementary to the target sequence, nonspecific amplification is not detected (18) . This type of sequence detection system has been used for both quantitative PCR (1, 3, 5, 22) and RT-PCR (4) for specific gene targets. We report here that by adding a fluorescently labeled internal probe, we have been able to develop a PCR-based RT assay with the same basis as the original PERT assay, but with several advantages: (i) as a one-step assay, requiring less labor and sample handling, which minimizes the risk of sample cross-contamination; (ii) since no post-PCR analysis is necessary, quantitative results are generated in less time; and (iii) the assay spans a large dynamic range, which eliminates the need for extensive sample dilution.
MATERIALS AND METHODS

Reagents
Synthetic oligonucleotide primers were obtained from Baron Biotech
Sho r t Technical Repo r t s
(Milford, CT, USA). The fluorescently labeled oligonucleotide hybridization probe was made by PE Applied Biosystems (Foster City, CA, USA). Deoxynucleotides were from the TaqMan ™ PCR Core Reagent Kit (Perkin-Elmer, Norwalk, CT, USA). MS2 RNA was from Boehringer Mannheim (Indianapolis, IN, USA).
AMV-RT (spec. activity = 96 830 U/ mg, mol wt = 160 000 g/mol) and recombinant human immunodeficiency virus type 1 (HIV-1)-RT (spec. activity = 5000 U/mg, mol wt = 125 000 g/mol) were obtained from Boehringer Mannheim. Recombinant Moloney murine leukemia virus (MuLV)-RT (spec. activity = 350 000 U/mg, mol wt = 80 000 g/mol) and recombinant RNase Inhibitor were from Perkin-Elmer. AmpliTaq Gold ™ DNA Polymerase was obtained from Perkin-Elmer.
Reagents for RT-PCR were from the TaqMan PCR Core Reagent Kit. Potassium chloride, 0.5 M EDTA and glycerol were obtained from Sigma Chemical (St. Louis, MO, USA), 1 M Tris-HCl, pH 7.5, was from Life Technologies (Gaithersburg, MD, USA), dithiothreitol (DTT) was from Fisher Scientific (Pittsburgh, PA, USA) and 10% Triton ® X-100 was from Boehringer Mannheim. RNase, DNase and Pronase-free water was molecular biology grade (5 Prime →3 Prime, Boulder, CO, USA). 
Viruses
Sample Preparation
We calculated the number of molecules from the specific activity provided by the manufacturer for each purified RT enzyme. Enzymes were diluted serially in the sample dilution Buffer A (50 mM KCl, 25 mM Tris-HCl, pH 7.5, 5 mM DTT, 0.25 mM EDTA, 0.025% Triton X-100, 50% glycerol) to the appropriate concentration such that 5 µ L of sample would contain the desired number of molecules. AMV-RT was used as the standard, serially diluted and assayed at concentrations ranging from 1 molecule (2.58 × 10 -11 U) to 1 million molecules (2.58 ×10 -5 U) of enzyme per 5 µ L. Purchased purified AMV and MuLV viruses were diluted serially to the desired level of virus particles in Buffer A based on supplier's specifications of number of vp/mL. Five milliliters of SRV-and MuLV-infected, cellculture supernatants were filtered and pelleted by ultracentrifugation as described (19) . Viral pellets were then resuspended in 150 µ L PBS. Virus particle counts were determined by Advanced Biotechnologies Inc. by negative stain transmission electron microscopy (SRV = 9.41 × 10 8 vp/mL; MuLV = 3.05 ×10 8 vp/mL). These viruses were diluted to the desired level of particles in Buffer A for analysis. In addition, a portion of the MuLV-infected, cell-culture supernatant was diluted in Buffer A based on the vp count provided by Advanced Biotechnologies Inc. and assayed directly without filtration or ultra - centrifugation. For uninfected control cell supernatants, 5 mL were filtered and pelleted as above and resuspended in 150 µ L of Buffer A for assay. For preparation of IMR90 human cell extracts, a sample was frozen and thawed 3 times and sonicated for 1 min. Cell debris was pelleted at 1800 × gfor 10 min. The supernatant was assayed in the fluorescent PERT assay, and protein concentration was determined by Lowry assay (Pierce Chemical, Rockford, IL, USA).
Fluorescent PERT Assay
The assay was performed in separate rooms for master mixture preparation and sample handling, and techniques to prevent cross-contamination were practiced. Annealed primer/template was prepared for each test or control sample by mixing 0.3 µ g of MS2 RNA with 10
Vol. 
RESULTS AND DISCUSSION
During the PCR amplification step of the fluorescent PERT assay, the nucleolytic activity of the TaqDNA polymerase cleaves the fluorescently tagged probe releasing the reporter dye and generating a quantifiable increase in fluorescent emission that is measured by a detector. The PCR cycle, where the signal becomes detectable, correlates with the concentration of RT enzyme in the sample (5). The instrument calculates a normalized reporter dye value ( ∆ R n ) for each sample, based on interfering fluorescence fluctuations in the internal passive reference dye and the "no template buffer control" (4, 5, 18 ). An amplification plot of ∆ R n vs. amplification cycle for serially diluted AMV-RT standard is shown in Figure 1A . The plot depicts that point during amplification where the emission for each sample rises over the baseline. As the number of starting enzyme molecules decreases, the amplification plot shifts toward the right, indicating that more amplification cycles are required to surpass the baseline fluorescence. A threshold is established (based on the variability of the baseline data), and results are then reported interms of cycle threshold (C T ), which is the cycle at which the emission for a particular sample crosses the threshold (4, 5, 18) . A standard curve is generated by plotting C T values vs. the log of the starting number of active molecules in each dilution of the AMV-RT standard ( Figure 1B) . The number of AMV-RT molecule equivalents can then be interpolated from the curve for samples containing unknown quantities of active RT. The linearity of the curve over a wide range of active RT molecules demonstrates the broad dynamic range of this assay.
The fluorescent PERT assay has been optimized for Mg 2+ concentration, probe and primer concentration, annealing/extension temperature and the length of the reverse transcription step to maximize the fluorescent signal while minimizing background. Reduction of the reverse transcription incubation step to 30 min did not compromise the detection limit of one molecule of active AMV-RT ( Table 1 ). The 112-bp PCR product is visible by ethidiumstained agarose gel down to 10 molecules of AMV-RT ( Figure 2, lane 2) . We assessed assay reproducibility by calculating both the intra-assay and inter-assay coefficient of variation (CV) from the mean C T and the standard deviation for 4 independent assays (data not shown). The average intra-assay CV range for C T was 1.7%-2.7%. ual sample range of 1.4%-6.5%. The greatest variability in C T was seen in the 1-and 10-molecule dilutions of AMV-RT. Most of these samples had an intra-assay CV for C T in the range of 3.1%-6.6% with an inter-assay CV of 6.5% and 3.6% for 1 and 10 molecules, respectively. The 1-molecule point was indistinguishable from the buffer control in 2 of the 4 assays (data not shown). In one assay, 12 replicates of the 1-molecule dilution produced C T values ranging from 32.86-38.25 (data not shown). This is not surprising because the probability of one molecule being present is expected to follow a Poisson distribution. High specificity is maintained in part by the design of the system. The TaqDNA polymerase enzyme requires that both the primers and probe be complementary to the target sequence for nucleolytic cleavage and generation of fluorescent emission. In addition, the use of AmpliTaq Gold, which remains in an inactive state until a temperature well above primer annealing is reached, minimizes primer dimer formation and amplification of nonspecific products (18) (Figure 2 ). Because the TaqDNA polymerase is inactive during the RT step, the background seen in the original PERT assay (19) that is due to RTlike activity of the TaqDNA polymerase, is minimal in this assay ( Table  1 , Buffer control; Figure 2, lane 16) .
Because the fluorescent PERT assay was highly sensitive and reproducible for detecting active AMV-RT, we were interested in determining the ability of this assay to detect active RT from other sources. On a per molecule basis, both recombinant HIV-1-RT and recombinant MuLV-RT produced signals, which were 5-fold-10-fold lower than the calculated number of molecules (Table 1; Figure 2 ). Differences in assay sensitivity for each of the enzymes can arise for many reasons including differences in enzyme kinetics, substrate optima or vendor unit definitions. Because avian and murine type C viruses and HIV-1 contain 10-110 RT molecules per virion (8-10,15,16) , the fluorescent PERT assay should be able to detect the equivalent of 1-10 virions for each of these viruses. To test this, stocks of AMV and MuLV viruses were purchased, while SRV-1 and MuLV viruses were pelleted by us for testing in the fluorescent PERT assay. Particle counts were provided or determined for all viruses, and none of them were centrifuged again once particle counts were known. All 4 viruses were detectable at 1 vp per test sample (Table 1; Figure 2 ). AMV gave a signal that was approximately 5-fold-10-fold lower than the calculated range of RT molecules, while the other viruses fell within the expected range. However, because the viruses were pelleted before virus particle counts were measured, it is possible that we might not dilute to single particles because of aggregation caused by centrifugation. To address this possibility, an unpelleted portion of the same MuLV-infected cell-culture supernatant was diluted according to the particle count value and assayed in parallel to the MuLV preparation that had been counted. The unpelleted sample produced a signal that was 3-fold-8-fold higher than the pelleted virus (Table 1 ; Figure 2 , lanes 25-28). These results indicate that ultracentrifugation did not have an appreciable effect on the PERT signal and demonstrate the ability of the fluorescent PERT assay to detect extremely low levels of retroviruses.
Some cellular polymerases are capable of using RNA as templates and therefore, can produce nonspecific amplification products in a PCR-based RT assay (2, 6, 13, 14, 19, 21, 23) . To address this issue, we have tested various negative control supernatants in the fluorescent PERT assay. A low-level fluorescence equivalent to less than 10 molecules of active AMV-RT was generated by all the control-cell supernatants tested (Table 1 ). When IMR90 cell extract was assayed, the resulting fluorescent PERT signal was equivalent to 23 molecules of AMV-RT, suggesting that the background for cell extracts might be greater than for cell supernatants. For both cell supernatants and cell extract, there was no distinct 112-bp PCR product when analyzed on an agarose gel (Figure 2, lanes 29-33) . It is expected that the fluorescence generated by cellular polymerases can vary based on either cell type or growth condition. Because of this background fluorescence, it is important to include appropriate controls in this assay.
Highly sensitive PCR-based RT assays can play an important role in the characterization of mutant enzyme activity, the detection of adventitious retroviral agents and detecting and quantitating viral load [in HIV-infected patients (2,6), for example]. We have developed a new fluorescent PCRbased RT assay and demonstrated its sensitivity and specificity for detection of both purified RTs and viruses. This fluorescent PERT assay has the advantage of higher-throughput retroviral detection because of shorter assay time, and, as a one-step assay, the risk of cross-contamination during PCR is minimized. We do acknowledge that, depending on concentration, some samples might have to be pelleted before testing; however, in most cases, because of the high sensitivity of the assay, pelleting is unnecessary. In addition, because the quantitation is based on the threshold cycle measured during the exponential phase of product accumulation, results are potentially more accurate than end-product quantitation after saturation (20) . This assay should therefore improve the ability to detect and quantitate retroviral RT and infection. One limitation to this assay, of course, is that an ABI 7700 Sequence Detector or equivalent is necessary.
INTRODUCTION
The recently developed DNA microarray technology (1,5) represents a further step towards high-throughput analysis of complex biological samples. It involves thousands of DNA samples (complete cDNAs or expressed sequence tags [ESTs]) immobilized at very high density on solid supports, usually glass surfaces. Such "DNA chips" are then hybridized with fluorescently labeled probes derived from mRNAs isolated from tissues of interest, and the arrays are scanned to quantitatively evaluate hybridization signals produced from the individual dots. This arrangement allows parallel monitoring of all transcripts with corresponding cDNAs that have been placed on the chip. Moreover, direct comparison of gene expression in two tissues can be made by simultaneous hybridization of corresponding probes labeled with different fluorochromes. This approach has been successfully used to study gene expression in Arabidopsis (6), human (2,7) and yeast (3) .
In spite of the advantages offered, the widespread use of DNA microarrays is currently restricted by difficulties associated with equipment allowing the high-precision delivery of DNA samples. A custom-made instrument designed especially for this purpose has been described (8); however, there are technical difficulties associated with its construction, and it represents a substantial financial investment. The Biomek ® 2000 Laboratory Automation Workstation (Beckman Instruments, Fullerton, CA, USA) is used for liquid handling and other automated operations in many laboratories. Since it has very good spatial positioning capabilities, we have investigated whether it might be possible to modify this workstation to deliver samples at high densities onto microscope slides to produce DNA microarrays. In this report, we describe low-cost modifications that allow reproducible printing of arrays on glass containing up to 3000 DNA elements.
MATERIALS AND METHODS
Configuration of the Workstation
The Biomek 2000 Workstation was equipped with right-and left-side modules (Part Nos. 609047 and 609048; Beckman Instruments) and installed in a Nuaire ™Class II Type A/B3 Laminar Flow Hood (Nuaire, Plymouth, MN, USA). Most of the components used for DNA printing [e.g., the high density replicating (HDR) tool used as the basis for constructing the DNA printing tool, the air fan and three reservoirs] were purchased as a part of the 96 HDR System (Beckman Instruments). Four labware holders (Part No. 609120; Beckman Instruments) were used for positioning the microplates and reservoirs on the Biomek 2000 work surface. The individual components were located as follows (see also Figure 2b ): Position A1 -fan; Position A2 -reservoir filled with 96% ethanol; Position A3 -microplate containing DNA samples; Position B1 -reservoir filled with deionized water; Position B2 -microplate covered with three sheets of Scott ® Absorbent Wipes. The samples were spotted directly from Concord PCR microplates (MJ Research, Watertown,
